LeonaBio, Inc. Peo Actually Paid Comp Amt
LeonaBio, Inc. (LONA) reported Peo Actually Paid Comp Amt of $1.95 million for the 12-month period ending 2025-12-31, per its DEF 14A filed 2026-05-11.
Financial Statements › Cash Flow › Other Cash Flow Items
ecd:PeoActuallyPaidCompAmt · last filed 2026-05-11
| Period end | Peo Actually Paid Comp Amt 12 month |
|---|---|
| 2025-12-31 | $1.95M DEF 14A · filed 2026-05-11 |
| 2024-12-31 | $1.15M DEF 14A · filed 2026-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |